Literature DB >> 6875831

Determination of hydralazine in human whole blood.

T M Ludden, L K Ludden, K E Wade, S R Allerheiligen.   

Abstract

The time required for the separation of plasma from the cellular components of blood can permit the in vitro loss of hydralazine. Thus, a high-performance liquid chromatographic (HPLC) procedure for the measurement of hydralazine in blood has been developed. 4-Methylhydralazine was used as an internal standard. The addition of p-anisaldehyde led to the formation of the p-anisaldehyde hydrazones of hydralazine and the internal standard. HPLC on a reverse-phase cyano column provided an analytical procedure in which the average relative standard deviation over the concentration range of 1-160 ng/ml was 8.3%. Hydralazine pyruvic acid hydrazone, a known circulating metabolite of hydralazine, yielded only 0.05 mole % hydralazine when submitted to this assay procedure.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6875831     DOI: 10.1002/jps.2600720624

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  2 in total

1.  Assay for hydralazine as its stable p-nitrobenzaldehyde hydrazone.

Authors:  H A Semple; Y K Tam; S Tin; R T Coutts
Journal:  Pharm Res       Date:  1988-06       Impact factor: 4.200

Review 2.  Clinical pharmacokinetics and therapeutic use of hydralazine in congestive heart failure.

Authors:  J P Mulrow; M H Crawford
Journal:  Clin Pharmacokinet       Date:  1989-02       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.